1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Canadian Foundation for Women's Health General Research Grant is a grant from the Canadian Foundation for Women's Health (CFWH) that funds researchers and healthcare professionals committed to advancing women's sexual and reproductive health in Canada. The program supports research in obstetrics, gynaecology, and related disciplines, with a focus on improving health outcomes for Canadian women at every stage of life.
CFWH champions national funding for women's health research and fosters international collaboration. Eligible applicants are researchers and clinicians with projects aligned with women's sexual and reproductive health.
Get alerted about grants like this
Save a search for “Canadian Foundation for Women's Health (CFWH)” or related topics and get emailed when new opportunities appear.
Search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Vice-President Research and Innovation Undergraduate Research at Lakehead Lakehead University Research Data Management (RDM) Institutional Strategy 2023 Postdoctoral Fellows and Visiting Scholars Internal Funding & Awards Ethics & Research Integrity Innovation, Partnerships and Economic Development (IPED) Ingenuity - Business Incubator Research Centres and Institutes Analytical Services and Laboratories Research and Innovation Week CFWH General Research Grant The CFWH General Research Grants are awarded to those committed to finding solutions to the reproductive health issues that face women both in Canada and around the world.
Open to any area within the field of obstetrics and gynaecology, these grants aim to help make further advancements in women’s health treatment, research, and education. The Dawn Walker Grant is administered by the Canadian Foundation for Women's Health (CFWH) in support of health policy training and development for healthcare professionals.
For purposes of the Grant, healthcare professionals are defined as individuals or students working or learning in a healthcare field and whose success will benefit from an enhanced understanding of the development of better health program policy for children and women. Kitty Carr Research Grant The Kitty Carr Grant is awarded to those committed to prevention of maternal mortality in Canada.
Open to any area within the field of obstetrics, health systems or policy research, this grant aims to support research projects focussed on preventing all possible maternal deaths.
André Lalonde Bursary for the Work of Canadian Physicians within Canada in Areas of Special Needs The Purpose of the Fund was expanded in 2016 to include the support of Canadian physicians (students and young physicians) wishing to, or currently working with under-serviced Canadian population.
Priority will be given to the following: Health professionals working to improve aboriginal women’s health Health professionals working with under-service groups Practitioners working towards improvement of nutrition in pregnancy and newborns http://cfwh. org/guidelines-and-application-forms/ Canadian Foundation for Women's Health
Based on current listing details, eligibility includes: Researchers and healthcare professionals committed to women's sexual and reproductive health, particularly in obstetrics and gynaecology. Applicants should confirm final requirements in the official notice before submission.
Current published award information indicates Not specified Always verify allowable costs, matching requirements, and funding caps directly in the sponsor documentation.
The current target date is rolling deadlines or periodic funding windows. Build your timeline backwards from this date to cover registrations, approvals, attachments, and final submission checks.
Federal grant success rates typically range from 10-30%, varying by agency and program. Build a strong proposal with clear objectives, measurable outcomes, and a well-justified budget to improve your chances.
Requirements vary by sponsor, but typically include a project narrative, budget justification, organizational capability statement, and key personnel CVs. Check the official notice for the complete list of required attachments.
Yes — AI tools like Granted can help research funders, draft proposal sections, and check compliance. However, always review and customize AI-generated content to reflect your organization's unique strengths and the specific requirements of the solicitation.
Review timelines vary by funder. Federal agencies typically take 3-6 months from submission to award notification. Foundation grants may be faster, often 1-3 months. Check the program's timeline in the official solicitation for specific dates.
Many federal programs offer multi-year funding or allow competitive renewals. Check the official solicitation for continuation and renewal policies. Non-competing continuation applications are common for multi-year awards.
-Purpose. This Funding Opportunity Announcement (FOA) encourages Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) that propose to develop, standardize, and validate new and innovative assays, integrated strategies, or batteries of assays that determine or predict specific organ toxicities (e.g., ocular, dermal, hematotoxicity, cardiotoxicity, gastrointestinal toxicity, hepatotoxicity, nephrotoxicity, ototoxicity, olfactory loss, bladder toxicity, neurotoxicity, pulmonary toxicity, endocrine toxicity, and pancreatic beta cell toxicity), resulting from both acute and chronic exposures to various chemicals, environmental pollutants, biologics and therapeutic molecules or drugs. In addition, this FOA encourages the development, standardization, and validation of new models of arthritis, convulsion, infection and shock. New approaches for high throughput toxicity screening that involves the use of molecular endpoints, computer modeling, proteomics, genomics and epigenomics and the development of virtual tissues are also encouraged as are development of 3-dimensional organ models for toxicity evaluation. -Mechanism of Support. This FOA will utilize the SBIR (R43/R44) grant mechanisms for Phase I, Phase II, and Fast-Track applications and runs in parallel with a FOA of identical scientific scope, PA-09-007, which encourages applications under the Small Business Technology Transfer (STTR) (R41/R42) grant mechanisms. Funding Opportunity Number: PA-09-006. Assistance Listing: 93.113,93.173,93.361,93.389,93.837,93.846,93.847,93.848,93.849,93.859,93.867. Funding Instrument: G. Category: ED,ENV,FN,HL.
Purpose. This Funding Opportunity Announcement (FOA), issued by the National Cancer Institute (NCI), National Institutes of Health (NIH), invites Small Business Innovation Research (SBIR) cooperative agreement applications from small business concerns (SBCs) that propose to develop new, or to improve existing application(s) of nanotechnology-based therapeutics or/and in vivo diagnostics. This FOA will specifically support pre-clinical optimization and testing of these cancer-relevant nanotechnology applications against the intended cancer type. The proposed projects must be milestone-driven and must be clearly directed toward development of an ultimate commercial product. The outcomes are expected to advance the discovery and pre-clinical optimization phase so that an Investigational New Drug (IND) or Investigational Device Exemptions (IDE) application could be submitted to the Food and Drug Administration (FDA) by the end or shortly after completion of the Phase II project period. To facilitate these steps, the NCI will assist the awardees in various ways, including the support through the NCI-sponsored Nanotechnology Characterization Laboratory. This FOA will NOT support basic research projects, studies on disease mechanisms, and clinical trials. Mechanism of Support. This FOA will utilize the SBIR (U43/U44) cooperative agreement mechanisms for Phase I and Phase II applications. Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. The total amount awarded and the number of awards will depend upon the quality, duration, and costs of the applications received. Funding Opportunity Number: PAR-10-286. Assistance Listing: 93.393,93.394,93.395,93.396. Funding Instrument: CA. Category: ED,HL. Award Amount: Up to $150K per award.
This Funding Opportunity Announcement (FOA) invites Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) for funding to perform research leading to the development of innovative technologies that may advance progress for early detection and assessment of individuals at risk and for early diagnosis, prognosis and follow-up of type 1 diabetes (T1D). Funding Opportunity Number: RFA-DK-15-024. Assistance Listing: 93.847. Funding Instrument: G. Category: FN,HL. Award Amount: $2M total program funding.